Thomas Friel

Thomas Friel has a diverse work experience in the pharmaceutical industry. Thomas started at the FDA in 2002 as a Drug Specialist and Consumer Safety Officer. In 2017, they joined Merck as an Associate Director in Quality Assurance with a focus on GMP Compliance. Thomas worked there until 2021 when they transitioned to Organon as an Associate Director in Quality Assurance. In 2022, Thomas became a Senior Director of QA Compliance at the Center for Breakthrough Medicines. Currently, they are working at Bristol Myers Squibb as a Director of GMP/GDP Audits and Inspection Readiness.

Thomas Friel obtained a Bachelor's Degree in Biology, General from La Salle University between 1995 and 1998. Later on, they pursued a Master's Degree in Quality Assurance/Regulatory Affairs from Temple University Graduate School, completing it by 2009. Additionally, they earned a Biomanufacturing Process Certificate from North Carolina State University in 2013.